nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS1—kidney cancer	0.466	0.636	CbGaD
Bismuth Subsalicylate—PTGS2—kidney cancer	0.266	0.364	CbGaD
Bismuth Subsalicylate—TF—urine—kidney cancer	0.0125	0.417	CbGeAlD
Bismuth Subsalicylate—PTGS2—nephron—kidney cancer	0.00443	0.147	CbGeAlD
Bismuth Subsalicylate—TF—renal system—kidney cancer	0.00307	0.102	CbGeAlD
Bismuth Subsalicylate—TF—kidney—kidney cancer	0.00297	0.0987	CbGeAlD
Bismuth Subsalicylate—TF—gonad—kidney cancer	0.00275	0.0915	CbGeAlD
Bismuth Subsalicylate—PTGS1—renal system—kidney cancer	0.00091	0.0303	CbGeAlD
Bismuth Subsalicylate—PTGS1—kidney—kidney cancer	0.00088	0.0293	CbGeAlD
Bismuth Subsalicylate—PTGS2—renal system—kidney cancer	0.00087	0.0289	CbGeAlD
Bismuth Subsalicylate—PTGS2—kidney—kidney cancer	0.000841	0.028	CbGeAlD
Bismuth Subsalicylate—PTGS1—cardiac atrium—kidney cancer	0.000815	0.0271	CbGeAlD
Bismuth Subsalicylate—Constipation—Temsirolimus—kidney cancer	0.000552	0.00346	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Paclitaxel—kidney cancer	0.00055	0.00345	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Sorafenib—kidney cancer	0.000547	0.00343	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Pazopanib—kidney cancer	0.000541	0.00339	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Pazopanib—kidney cancer	0.000535	0.00336	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Dactinomycin—kidney cancer	0.000534	0.00335	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Sunitinib—kidney cancer	0.000534	0.00335	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Pazopanib—kidney cancer	0.000529	0.00331	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Capecitabine—kidney cancer	0.000522	0.00327	CcSEcCtD
Bismuth Subsalicylate—Pain—Pazopanib—kidney cancer	0.00052	0.00326	CcSEcCtD
Bismuth Subsalicylate—Erythema—Sorafenib—kidney cancer	0.000511	0.0032	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Temsirolimus—kidney cancer	0.00051	0.0032	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Dactinomycin—kidney cancer	0.000505	0.00317	CcSEcCtD
Bismuth Subsalicylate—Deafness—Capecitabine—kidney cancer	0.000503	0.00315	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Paclitaxel—kidney cancer	0.000501	0.00314	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Sorafenib—kidney cancer	0.0005	0.00313	CcSEcCtD
Bismuth Subsalicylate—Stinging—Doxorubicin—kidney cancer	0.000493	0.00309	CcSEcCtD
Bismuth Subsalicylate—Erythema—Sunitinib—kidney cancer	0.000491	0.00308	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Sunitinib—kidney cancer	0.000481	0.00302	CcSEcCtD
Bismuth Subsalicylate—Oedema—Everolimus—kidney cancer	0.00048	0.00301	CcSEcCtD
Bismuth Subsalicylate—Infection—Everolimus—kidney cancer	0.000477	0.00299	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Vincristine—kidney cancer	0.000475	0.00298	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dactinomycin—kidney cancer	0.000465	0.00292	CcSEcCtD
Bismuth Subsalicylate—Oedema—Erlotinib—kidney cancer	0.000463	0.0029	CcSEcCtD
Bismuth Subsalicylate—Infection—Erlotinib—kidney cancer	0.00046	0.00288	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vinblastine—kidney cancer	0.000459	0.00288	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Capecitabine—kidney cancer	0.000459	0.00288	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Doxorubicin—kidney cancer	0.000458	0.00287	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Everolimus—kidney cancer	0.000458	0.00287	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Temsirolimus—kidney cancer	0.000457	0.00286	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Capecitabine—kidney cancer	0.000452	0.00283	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Temsirolimus—kidney cancer	0.000442	0.00277	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Erlotinib—kidney cancer	0.000442	0.00277	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Paclitaxel—kidney cancer	0.000431	0.0027	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Pazopanib—kidney cancer	0.00043	0.0027	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Gemcitabine—kidney cancer	0.000428	0.00268	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Everolimus—kidney cancer	0.000427	0.00268	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Temsirolimus—kidney cancer	0.000427	0.00268	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Everolimus—kidney cancer	0.000423	0.00265	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vinblastine—kidney cancer	0.000419	0.00263	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Everolimus—kidney cancer	0.000417	0.00262	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pazopanib—kidney cancer	0.000416	0.00261	CcSEcCtD
Bismuth Subsalicylate—Infection—Sorafenib—kidney cancer	0.000414	0.0026	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vinblastine—kidney cancer	0.000412	0.00258	CcSEcCtD
Bismuth Subsalicylate—Pain—Vinblastine—kidney cancer	0.000412	0.00258	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Capecitabine—kidney cancer	0.000411	0.00258	CcSEcCtD
Bismuth Subsalicylate—Pain—Everolimus—kidney cancer	0.000411	0.00257	CcSEcCtD
Bismuth Subsalicylate—Constipation—Everolimus—kidney cancer	0.000411	0.00257	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Temsirolimus—kidney cancer	0.00041	0.00257	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Erlotinib—kidney cancer	0.000408	0.00256	CcSEcCtD
Bismuth Subsalicylate—Rash—Temsirolimus—kidney cancer	0.000407	0.00255	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Temsirolimus—kidney cancer	0.000407	0.00255	CcSEcCtD
Bismuth Subsalicylate—Headache—Temsirolimus—kidney cancer	0.000404	0.00253	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Erlotinib—kidney cancer	0.000403	0.00252	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pazopanib—kidney cancer	0.000402	0.00252	CcSEcCtD
Bismuth Subsalicylate—Oedema—Sunitinib—kidney cancer	0.000401	0.00251	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Paclitaxel—kidney cancer	0.000398	0.0025	CcSEcCtD
Bismuth Subsalicylate—Infection—Sunitinib—kidney cancer	0.000398	0.0025	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Sorafenib—kidney cancer	0.000397	0.00249	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Vinblastine—kidney cancer	0.000397	0.00249	CcSEcCtD
Bismuth Subsalicylate—Pain—Erlotinib—kidney cancer	0.000396	0.00248	CcSEcCtD
Bismuth Subsalicylate—Constipation—Erlotinib—kidney cancer	0.000396	0.00248	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Everolimus—kidney cancer	0.000396	0.00248	CcSEcCtD
Bismuth Subsalicylate—Erythema—Gemcitabine—kidney cancer	0.000394	0.00247	CcSEcCtD
Bismuth Subsalicylate—Asthma—Capecitabine—kidney cancer	0.000389	0.00244	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Pazopanib—kidney cancer	0.000387	0.00242	CcSEcCtD
Bismuth Subsalicylate—Rash—Pazopanib—kidney cancer	0.000383	0.0024	CcSEcCtD
Bismuth Subsalicylate—Nausea—Temsirolimus—kidney cancer	0.000383	0.0024	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pazopanib—kidney cancer	0.000383	0.0024	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Sunitinib—kidney cancer	0.000382	0.0024	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—kidney cancer	0.000381	0.00239	CcSEcCtD
Bismuth Subsalicylate—Headache—Pazopanib—kidney cancer	0.000381	0.00239	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dactinomycin—kidney cancer	0.00038	0.00238	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Everolimus—kidney cancer	0.000379	0.00238	CcSEcCtD
Bismuth Subsalicylate—Infection—Dactinomycin—kidney cancer	0.000377	0.00236	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Capecitabine—kidney cancer	0.000373	0.00234	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Sorafenib—kidney cancer	0.000367	0.0023	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Erlotinib—kidney cancer	0.000366	0.0023	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—kidney cancer	0.000365	0.00229	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Sorafenib—kidney cancer	0.000362	0.00227	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dactinomycin—kidney cancer	0.000362	0.00227	CcSEcCtD
Bismuth Subsalicylate—Nausea—Pazopanib—kidney cancer	0.000361	0.00226	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—kidney cancer	0.000361	0.00226	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Paclitaxel—kidney cancer	0.000358	0.00225	CcSEcCtD
Bismuth Subsalicylate—Pain—Sorafenib—kidney cancer	0.000356	0.00223	CcSEcCtD
Bismuth Subsalicylate—Constipation—Sorafenib—kidney cancer	0.000356	0.00223	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Capecitabine—kidney cancer	0.000354	0.00222	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Paclitaxel—kidney cancer	0.000354	0.00222	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Sunitinib—kidney cancer	0.000353	0.00221	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Sunitinib—kidney cancer	0.000349	0.00219	CcSEcCtD
Bismuth Subsalicylate—Constipation—Sunitinib—kidney cancer	0.000343	0.00215	CcSEcCtD
Bismuth Subsalicylate—Pain—Sunitinib—kidney cancer	0.000343	0.00215	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Everolimus—kidney cancer	0.00034	0.00213	CcSEcCtD
Bismuth Subsalicylate—Oedema—Vincristine—kidney cancer	0.000339	0.00213	CcSEcCtD
Bismuth Subsalicylate—Infection—Vincristine—kidney cancer	0.000337	0.00211	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—kidney cancer	0.000337	0.00211	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Sorafenib—kidney cancer	0.000331	0.00208	CcSEcCtD
Bismuth Subsalicylate—Erythema—Paclitaxel—kidney cancer	0.00033	0.00207	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dactinomycin—kidney cancer	0.00033	0.00207	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vinblastine—kidney cancer	0.00033	0.00207	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Sorafenib—kidney cancer	0.000329	0.00207	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Everolimus—kidney cancer	0.000328	0.00206	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Erlotinib—kidney cancer	0.000328	0.00205	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Capecitabine—kidney cancer	0.000327	0.00205	CcSEcCtD
Bismuth Subsalicylate—Pain—Dactinomycin—kidney cancer	0.000325	0.00204	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vincristine—kidney cancer	0.000323	0.00203	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Paclitaxel—kidney cancer	0.000323	0.00203	CcSEcCtD
Bismuth Subsalicylate—Oedema—Gemcitabine—kidney cancer	0.000322	0.00202	CcSEcCtD
Bismuth Subsalicylate—Infection—Gemcitabine—kidney cancer	0.00032	0.002	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vinblastine—kidney cancer	0.000319	0.002	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Everolimus—kidney cancer	0.000317	0.00199	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Sunitinib—kidney cancer	0.000317	0.00199	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Erlotinib—kidney cancer	0.000317	0.00199	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dactinomycin—kidney cancer	0.000313	0.00196	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Capecitabine—kidney cancer	0.000311	0.00195	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Gemcitabine—kidney cancer	0.000307	0.00192	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vinblastine—kidney cancer	0.000306	0.00192	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Erlotinib—kidney cancer	0.000306	0.00192	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Everolimus—kidney cancer	0.000305	0.00191	CcSEcCtD
Bismuth Subsalicylate—Rash—Everolimus—kidney cancer	0.000303	0.0019	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Everolimus—kidney cancer	0.000302	0.0019	CcSEcCtD
Bismuth Subsalicylate—Headache—Vinblastine—kidney cancer	0.000302	0.00189	CcSEcCtD
Bismuth Subsalicylate—Headache—Everolimus—kidney cancer	0.000301	0.00189	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dactinomycin—kidney cancer	0.0003	0.00188	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—kidney cancer	0.000296	0.00185	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vincristine—kidney cancer	0.000295	0.00185	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Sorafenib—kidney cancer	0.000295	0.00185	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Erlotinib—kidney cancer	0.000295	0.00185	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Capecitabine—kidney cancer	0.000294	0.00184	CcSEcCtD
Bismuth Subsalicylate—Rash—Erlotinib—kidney cancer	0.000292	0.00183	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Erlotinib—kidney cancer	0.000292	0.00183	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—kidney cancer	0.000291	0.00182	CcSEcCtD
Bismuth Subsalicylate—Headache—Erlotinib—kidney cancer	0.00029	0.00182	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Capecitabine—kidney cancer	0.00029	0.00182	CcSEcCtD
Bismuth Subsalicylate—Pain—Vincristine—kidney cancer	0.00029	0.00182	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vincristine—kidney cancer	0.00029	0.00182	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vinblastine—kidney cancer	0.000286	0.00179	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Gemcitabine—kidney cancer	0.000286	0.00179	CcSEcCtD
Bismuth Subsalicylate—Nausea—Everolimus—kidney cancer	0.000285	0.00179	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Sorafenib—kidney cancer	0.000285	0.00179	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Sunitinib—kidney cancer	0.000284	0.00178	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Gemcitabine—kidney cancer	0.00028	0.00175	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Sorafenib—kidney cancer	0.000276	0.00173	CcSEcCtD
Bismuth Subsalicylate—Constipation—Gemcitabine—kidney cancer	0.000275	0.00172	CcSEcCtD
Bismuth Subsalicylate—Pain—Gemcitabine—kidney cancer	0.000275	0.00172	CcSEcCtD
Bismuth Subsalicylate—Nausea—Erlotinib—kidney cancer	0.000275	0.00172	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Sunitinib—kidney cancer	0.000274	0.00172	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Paclitaxel—kidney cancer	0.000272	0.0017	CcSEcCtD
Bismuth Subsalicylate—Erythema—Capecitabine—kidney cancer	0.000271	0.0017	CcSEcCtD
Bismuth Subsalicylate—Oedema—Paclitaxel—kidney cancer	0.000269	0.00169	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Vincristine—kidney cancer	0.000268	0.00168	CcSEcCtD
Bismuth Subsalicylate—Infection—Paclitaxel—kidney cancer	0.000268	0.00168	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Capecitabine—kidney cancer	0.000265	0.00166	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Sunitinib—kidney cancer	0.000265	0.00166	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Gemcitabine—kidney cancer	0.000265	0.00166	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Sorafenib—kidney cancer	0.000265	0.00166	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—kidney cancer	0.000265	0.00166	CcSEcCtD
Bismuth Subsalicylate—Rash—Sorafenib—kidney cancer	0.000263	0.00165	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Sorafenib—kidney cancer	0.000263	0.00165	CcSEcCtD
Bismuth Subsalicylate—Headache—Sorafenib—kidney cancer	0.000261	0.00164	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dactinomycin—kidney cancer	0.00026	0.00163	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Paclitaxel—kidney cancer	0.000257	0.00161	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Sunitinib—kidney cancer	0.000255	0.0016	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Gemcitabine—kidney cancer	0.000254	0.00159	CcSEcCtD
Bismuth Subsalicylate—Rash—Sunitinib—kidney cancer	0.000253	0.00158	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Sunitinib—kidney cancer	0.000253	0.00158	CcSEcCtD
Bismuth Subsalicylate—Headache—Sunitinib—kidney cancer	0.000251	0.00157	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—kidney cancer	0.000251	0.00157	CcSEcCtD
Bismuth Subsalicylate—Nausea—Sorafenib—kidney cancer	0.000248	0.00155	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dactinomycin—kidney cancer	0.000241	0.00151	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Paclitaxel—kidney cancer	0.000239	0.0015	CcSEcCtD
Bismuth Subsalicylate—Rash—Dactinomycin—kidney cancer	0.000239	0.0015	CcSEcCtD
Bismuth Subsalicylate—Nausea—Sunitinib—kidney cancer	0.000238	0.00149	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Paclitaxel—kidney cancer	0.000237	0.00149	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Paclitaxel—kidney cancer	0.000234	0.00147	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vincristine—kidney cancer	0.000232	0.00145	CcSEcCtD
Bismuth Subsalicylate—Constipation—Paclitaxel—kidney cancer	0.00023	0.00144	CcSEcCtD
Bismuth Subsalicylate—Pain—Paclitaxel—kidney cancer	0.00023	0.00144	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—kidney cancer	0.000228	0.00143	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Gemcitabine—kidney cancer	0.000228	0.00143	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dactinomycin—kidney cancer	0.000225	0.00141	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vincristine—kidney cancer	0.000224	0.00141	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—kidney cancer	0.000223	0.0014	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Capecitabine—kidney cancer	0.000223	0.0014	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Paclitaxel—kidney cancer	0.000222	0.00139	CcSEcCtD
Bismuth Subsalicylate—Oedema—Capecitabine—kidney cancer	0.000221	0.00139	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Gemcitabine—kidney cancer	0.00022	0.00138	CcSEcCtD
Bismuth Subsalicylate—Infection—Capecitabine—kidney cancer	0.00022	0.00138	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vincristine—kidney cancer	0.000216	0.00135	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Paclitaxel—kidney cancer	0.000214	0.00134	CcSEcCtD
Bismuth Subsalicylate—Rash—Vincristine—kidney cancer	0.000214	0.00134	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vincristine—kidney cancer	0.000214	0.00134	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Paclitaxel—kidney cancer	0.000213	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Vincristine—kidney cancer	0.000212	0.00133	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—kidney cancer	0.000211	0.00132	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Capecitabine—kidney cancer	0.000211	0.00132	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Gemcitabine—kidney cancer	0.000205	0.00128	CcSEcCtD
Bismuth Subsalicylate—Rash—Gemcitabine—kidney cancer	0.000203	0.00127	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Gemcitabine—kidney cancer	0.000203	0.00127	CcSEcCtD
Bismuth Subsalicylate—Headache—Gemcitabine—kidney cancer	0.000202	0.00126	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vincristine—kidney cancer	0.000201	0.00126	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—kidney cancer	0.000201	0.00126	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Capecitabine—kidney cancer	0.000195	0.00122	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Capecitabine—kidney cancer	0.000192	0.0012	CcSEcCtD
Bismuth Subsalicylate—Nausea—Gemcitabine—kidney cancer	0.000191	0.0012	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Paclitaxel—kidney cancer	0.000191	0.00119	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—kidney cancer	0.00019	0.00119	CcSEcCtD
Bismuth Subsalicylate—Pain—Capecitabine—kidney cancer	0.000189	0.00119	CcSEcCtD
Bismuth Subsalicylate—Constipation—Capecitabine—kidney cancer	0.000189	0.00119	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—kidney cancer	0.000187	0.00117	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Paclitaxel—kidney cancer	0.000184	0.00116	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Capecitabine—kidney cancer	0.000182	0.00114	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Paclitaxel—kidney cancer	0.000178	0.00112	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Capecitabine—kidney cancer	0.000176	0.0011	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Capecitabine—kidney cancer	0.000175	0.0011	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—kidney cancer	0.000175	0.00109	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Paclitaxel—kidney cancer	0.000171	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—kidney cancer	0.000171	0.00107	CcSEcCtD
Bismuth Subsalicylate—Rash—Paclitaxel—kidney cancer	0.00017	0.00106	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Paclitaxel—kidney cancer	0.00017	0.00106	CcSEcCtD
Bismuth Subsalicylate—Headache—Paclitaxel—kidney cancer	0.000169	0.00106	CcSEcCtD
Bismuth Subsalicylate—Nausea—Paclitaxel—kidney cancer	0.00016	0.001	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Capecitabine—kidney cancer	0.000156	0.00098	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Capecitabine—kidney cancer	0.000151	0.000948	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Capecitabine—kidney cancer	0.000146	0.000916	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—kidney cancer	0.000144	0.000901	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—kidney cancer	0.000142	0.000893	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—kidney cancer	0.000142	0.000887	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Capecitabine—kidney cancer	0.000141	0.000881	CcSEcCtD
Bismuth Subsalicylate—Rash—Capecitabine—kidney cancer	0.000139	0.000874	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Capecitabine—kidney cancer	0.000139	0.000873	CcSEcCtD
Bismuth Subsalicylate—Headache—Capecitabine—kidney cancer	0.000138	0.000868	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—kidney cancer	0.000136	0.000852	CcSEcCtD
Bismuth Subsalicylate—Nausea—Capecitabine—kidney cancer	0.000131	0.000823	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—kidney cancer	0.000127	0.000794	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—kidney cancer	0.000125	0.000786	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—kidney cancer	0.000124	0.000777	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—kidney cancer	0.000122	0.000764	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—kidney cancer	0.000122	0.000764	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—kidney cancer	0.000117	0.000736	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—kidney cancer	0.000113	0.00071	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—kidney cancer	0.000113	0.000706	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000108	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000108	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	0.000107	0.00137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—L1CAM—kidney cancer	0.000105	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	0.000104	0.00134	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000104	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000101	0.0013	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Doxorubicin—kidney cancer	0.000101	0.000632	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—RAF1—kidney cancer	9.93e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	9.87e-05	0.00126	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—kidney cancer	9.75e-05	0.000611	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	9.73e-05	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ACY1—kidney cancer	9.56e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.56e-05	0.00122	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Doxorubicin—kidney cancer	9.42e-05	0.000591	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—RELA—kidney cancer	9.19e-05	0.00118	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	9.17e-05	0.00118	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Doxorubicin—kidney cancer	9.06e-05	0.000568	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	9.03e-05	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Doxorubicin—kidney cancer	8.98e-05	0.000563	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—kidney cancer	8.98e-05	0.000563	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—kidney cancer	8.93e-05	0.00056	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—IL2—kidney cancer	8.91e-05	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	8.9e-05	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	8.82e-05	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	8.62e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	8.62e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—RAF1—kidney cancer	8.6e-05	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Doxorubicin—kidney cancer	8.46e-05	0.000531	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—kidney cancer	8.28e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	8.22e-05	0.00105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.15e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PDHB—kidney cancer	8.13e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—POMC—kidney cancer	8.1e-05	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ANXA2—kidney cancer	7.95e-05	0.00102	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CCBL1—kidney cancer	7.64e-05	0.00098	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ACY1—kidney cancer	7.59e-05	0.000973	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—kidney cancer	7.57e-05	0.00097	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—RELA—kidney cancer	7.3e-05	0.000936	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCBL1—kidney cancer	7.24e-05	0.000929	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—MAPK3—kidney cancer	7.16e-05	0.000918	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	7.15e-05	0.000916	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	7.09e-05	0.00091	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.91e-05	0.000886	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.9e-05	0.000885	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.89e-05	0.000883	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.89e-05	0.000883	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.89e-05	0.000883	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—MAPK1—kidney cancer	6.81e-05	0.000873	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GLIPR1—kidney cancer	6.63e-05	0.000849	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPAT—kidney cancer	6.63e-05	0.000849	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	6.6e-05	0.000846	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KCNMA1—kidney cancer	6.59e-05	0.000845	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	6.57e-05	0.000842	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AMER1—kidney cancer	6.55e-05	0.00084	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.54e-05	0.000839	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.47e-05	0.00083	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PDHB—kidney cancer	6.45e-05	0.000827	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—KRAS—kidney cancer	6.43e-05	0.000825	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—kidney cancer	6.43e-05	0.000824	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	6.38e-05	0.000818	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	6.27e-05	0.000803	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.21e-05	0.000797	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APRT—kidney cancer	6.16e-05	0.00079	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—FH—kidney cancer	6.16e-05	0.00079	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ACY1—kidney cancer	6.14e-05	0.000787	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	6.1e-05	0.000781	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CCBL1—kidney cancer	6.07e-05	0.000778	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—kidney cancer	6.03e-05	0.000773	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.02e-05	0.000772	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PIK3CA—kidney cancer	5.91e-05	0.000758	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPC3—kidney cancer	5.79e-05	0.000742	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GRB7—kidney cancer	5.75e-05	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	5.75e-05	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—kidney cancer	5.72e-05	0.000733	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CA2—kidney cancer	5.63e-05	0.000722	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALAD—kidney cancer	5.49e-05	0.000704	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GPC3—kidney cancer	5.49e-05	0.000704	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.49e-05	0.000703	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ST3GAL2—kidney cancer	5.36e-05	0.000687	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITPR2—kidney cancer	5.35e-05	0.000685	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—kidney cancer	5.32e-05	0.000681	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPAT—kidney cancer	5.26e-05	0.000674	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GLIPR1—kidney cancer	5.26e-05	0.000674	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDH1A1—kidney cancer	5.24e-05	0.000671	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.24e-05	0.000671	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PDHB—kidney cancer	5.22e-05	0.000669	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.19e-05	0.000666	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	5.17e-05	0.000662	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.14e-05	0.000659	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ST3GAL2—kidney cancer	5.08e-05	0.000651	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—kidney cancer	5.03e-05	0.000644	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PGK1—kidney cancer	5.02e-05	0.000644	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC5A3—kidney cancer	5.02e-05	0.000644	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LDHB—kidney cancer	4.92e-05	0.000631	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.92e-05	0.00063	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CCBL1—kidney cancer	4.91e-05	0.000629	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FH—kidney cancer	4.89e-05	0.000627	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APRT—kidney cancer	4.89e-05	0.000627	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.88e-05	0.000625	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.82e-05	0.000618	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.78e-05	0.000613	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PGK1—kidney cancer	4.76e-05	0.00061	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC5A3—kidney cancer	4.76e-05	0.00061	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LDHB—kidney cancer	4.67e-05	0.000598	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SFRP2—kidney cancer	4.67e-05	0.000598	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPC3—kidney cancer	4.6e-05	0.000589	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA2—kidney cancer	4.47e-05	0.000573	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.47e-05	0.000573	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.44e-05	0.000569	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALAD—kidney cancer	4.36e-05	0.000559	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TCEB2—kidney cancer	4.35e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TCEB1—kidney cancer	4.35e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CA9—kidney cancer	4.27e-05	0.000547	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.26e-05	0.000546	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPAT—kidney cancer	4.26e-05	0.000545	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GLIPR1—kidney cancer	4.26e-05	0.000545	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ST3GAL2—kidney cancer	4.25e-05	0.000545	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.25e-05	0.000545	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.22e-05	0.000541	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.2e-05	0.000539	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.17e-05	0.000535	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.16e-05	0.000533	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDH1A1—kidney cancer	4.16e-05	0.000533	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—kidney cancer	4.13e-05	0.000529	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.11e-05	0.000527	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PGK1—kidney cancer	3.99e-05	0.000511	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC5A3—kidney cancer	3.99e-05	0.000511	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FH—kidney cancer	3.96e-05	0.000507	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APRT—kidney cancer	3.96e-05	0.000507	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA1—kidney cancer	3.92e-05	0.000503	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LDHB—kidney cancer	3.91e-05	0.000501	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.87e-05	0.000496	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPC3—kidney cancer	3.72e-05	0.000477	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.72e-05	0.000476	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA2—kidney cancer	3.65e-05	0.000468	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.63e-05	0.000466	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CRABP1—kidney cancer	3.63e-05	0.000465	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA2—kidney cancer	3.62e-05	0.000464	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL14—kidney cancer	3.54e-05	0.000453	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALAD—kidney cancer	3.53e-05	0.000452	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.52e-05	0.000451	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.51e-05	0.00045	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.51e-05	0.00045	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ST3GAL2—kidney cancer	3.44e-05	0.000441	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.42e-05	0.000438	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA9—kidney cancer	3.39e-05	0.000434	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ITPR2—kidney cancer	3.37e-05	0.000433	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDH1A1—kidney cancer	3.36e-05	0.000431	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.34e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.31e-05	0.000425	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF2—kidney cancer	3.29e-05	0.000422	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A3—kidney cancer	3.22e-05	0.000413	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PGK1—kidney cancer	3.22e-05	0.000413	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ITPR2—kidney cancer	3.2e-05	0.00041	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LDHB—kidney cancer	3.16e-05	0.000405	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.16e-05	0.000405	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.15e-05	0.000404	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.11e-05	0.000399	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ACHE—kidney cancer	3.08e-05	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—kidney cancer	3.08e-05	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SCARB1—kidney cancer	2.91e-05	0.000373	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.9e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CRABP1—kidney cancer	2.88e-05	0.000369	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PSMD7—kidney cancer	2.83e-05	0.000363	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.81e-05	0.00036	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.77e-05	0.000355	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA9—kidney cancer	2.74e-05	0.000352	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—kidney cancer	2.68e-05	0.000344	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSMD7—kidney cancer	2.68e-05	0.000344	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.68e-05	0.000344	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ITPR2—kidney cancer	2.68e-05	0.000343	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.68e-05	0.000343	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC5A5—kidney cancer	2.65e-05	0.000339	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A1—kidney cancer	2.56e-05	0.000328	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.53e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.48e-05	0.000318	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.47e-05	0.000317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—kidney cancer	2.44e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ACHE—kidney cancer	2.44e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A1—kidney cancer	2.42e-05	0.000311	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.41e-05	0.000309	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JUNB—kidney cancer	2.41e-05	0.000309	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CRABP1—kidney cancer	2.33e-05	0.000299	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SCARB1—kidney cancer	2.31e-05	0.000296	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTGS1—kidney cancer	2.29e-05	0.000293	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PSMD7—kidney cancer	2.25e-05	0.000288	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ITPR2—kidney cancer	2.17e-05	0.000278	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.16e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—kidney cancer	2.13e-05	0.000273	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—kidney cancer	2.13e-05	0.000273	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC5A5—kidney cancer	2.1e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.09e-05	0.000268	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A1—kidney cancer	2.03e-05	0.00026	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—kidney cancer	2.02e-05	0.000259	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—kidney cancer	1.98e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ACHE—kidney cancer	1.98e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—kidney cancer	1.96e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN2B—kidney cancer	1.96e-05	0.000251	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SCARB1—kidney cancer	1.87e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP1A1—kidney cancer	1.86e-05	0.000238	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS1—kidney cancer	1.85e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PSMD7—kidney cancer	1.82e-05	0.000233	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RAF1—kidney cancer	1.81e-05	0.000232	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—kidney cancer	1.72e-05	0.000221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.72e-05	0.00022	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A5—kidney cancer	1.7e-05	0.000218	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—kidney cancer	1.69e-05	0.000217	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—kidney cancer	1.62e-05	0.000208	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—kidney cancer	1.6e-05	0.000205	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.59e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.57e-05	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIF1A—kidney cancer	1.57e-05	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TSC2—kidney cancer	1.56e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—kidney cancer	1.56e-05	0.000199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.53e-05	0.000196	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP1A1—kidney cancer	1.48e-05	0.000189	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.39e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—kidney cancer	1.39e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APC—kidney cancer	1.38e-05	0.000177	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KIT—kidney cancer	1.38e-05	0.000177	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—kidney cancer	1.38e-05	0.000177	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—kidney cancer	1.37e-05	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK3—kidney cancer	1.3e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—BRAF—kidney cancer	1.3e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—kidney cancer	1.3e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK1—kidney cancer	1.24e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.21e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—kidney cancer	1.17e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—kidney cancer	1.1e-05	0.000141	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RAF1—kidney cancer	1.08e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—kidney cancer	1.08e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—kidney cancer	1.07e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTOR—kidney cancer	1.06e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—kidney cancer	1.06e-05	0.000135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—kidney cancer	1.04e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1B—kidney cancer	9.92e-06	0.000127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.81e-06	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTEN—kidney cancer	9.64e-06	0.000124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CTNNB1—kidney cancer	9.37e-06	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PTEN—kidney cancer	9.14e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—kidney cancer	8.9e-06	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK3—kidney cancer	7.81e-06	0.0001	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTEN—kidney cancer	7.65e-06	9.81e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—kidney cancer	7.59e-06	9.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK1—kidney cancer	7.43e-06	9.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—kidney cancer	7.1e-06	9.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—kidney cancer	7.02e-06	8.99e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—kidney cancer	6.8e-06	8.72e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—kidney cancer	6.45e-06	8.26e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTEN—kidney cancer	6.19e-06	7.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—kidney cancer	5.4e-06	6.92e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—kidney cancer	4.37e-06	5.6e-05	CbGpPWpGaD
